173 related articles for article (PubMed ID: 38164943)
61. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma.
Liu W; Du Q; Mei T; Wang J; Huang D; Qin T
BMC Cancer; 2024 Jan; 24(1):94. PubMed ID: 38233752
[TBL] [Abstract][Full Text] [Related]
62. A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients.
Guo Q; Li K; Jiang N; Zhou R; Rao XR; Wu CY
Aging (Albany NY); 2023 Sep; 15(18):9633-9660. PubMed ID: 37737707
[TBL] [Abstract][Full Text] [Related]
63. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
[TBL] [Abstract][Full Text] [Related]
64. Osimertinib resistance prognostic gene signature: STRIP2 is associated with immune infiltration and tumor progression in lung adenocarcinoma.
Zhang G; Guan H; Ning YL; Yao K; Tang H; Muhetaer G; Li H; Zhou J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15573-15588. PubMed ID: 37648810
[TBL] [Abstract][Full Text] [Related]
65. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
66. Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma.
Yu Q; Zhao L; Yan XX; Li Y; Chen XY; Hu XH; Bu Q; Lv XP
World J Surg Oncol; 2022 Jun; 20(1):183. PubMed ID: 35668494
[TBL] [Abstract][Full Text] [Related]
67. Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis.
Qin FL; Xu ZY; Yuan LQ; Chen WJ; Wei JB; Sun Y; Li SK
FEBS Open Bio; 2020 Sep; 10(9):1921-1933. PubMed ID: 32686362
[TBL] [Abstract][Full Text] [Related]
68. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
[TBL] [Abstract][Full Text] [Related]
69. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
Cao K; Ling X; Jiang X; Ma J; Zhu J
Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
[TBL] [Abstract][Full Text] [Related]
70. Molecular Characterization and Prognosis of Lactate-Related Genes in Lung Adenocarcinoma.
Guo Z; Hu L; Wang Q; Wang Y; Liu XP; Chen C; Li S; Hu W
Curr Oncol; 2023 Feb; 30(3):2845-2861. PubMed ID: 36975430
[TBL] [Abstract][Full Text] [Related]
71. A novel iTreg-related signature for prognostic prediction in lung adenocarcinoma.
Zhang J; Li Y; Yang Y; Huang J; Sun Y; Zhang X; Kong X
Cancer Sci; 2024 Jan; 115(1):109-124. PubMed ID: 38015097
[TBL] [Abstract][Full Text] [Related]
72. Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment.
Huang D; Tang E; Zhang T; Xu G
Front Immunol; 2022; 13():916284. PubMed ID: 35860256
[TBL] [Abstract][Full Text] [Related]
73. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
[TBL] [Abstract][Full Text] [Related]
74. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Chen G; Dong Z; Wu D; Chen Y
J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
[TBL] [Abstract][Full Text] [Related]
75. A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune Microenvironment of Early-Stage LUAD.
Zhao Z; Yin W; Peng X; Cai Q; He B; Shi S; Peng W; Tu G; Li Y; Li D; Tao Y; Peng M; Wang X; Yu F
Front Immunol; 2022; 13():872387. PubMed ID: 35693786
[TBL] [Abstract][Full Text] [Related]
76. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
77. Prognostic Hub Genes in the Immune Microenvironment of Lung Adenocarcinoma by Estimation.
Liu S; Tian W; Li B
Comb Chem High Throughput Screen; 2022; 25(1):77-89. PubMed ID: 33308118
[TBL] [Abstract][Full Text] [Related]
78. Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma.
Wang Y; Huang X; Fan H; Xu Y; Qi Z; Zhang Y; Huang Y
Aging (Albany NY); 2023 May; 15(10):4202-4235. PubMed ID: 37199651
[TBL] [Abstract][Full Text] [Related]
79. Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma.
Yang B; Rong X; Jiang C; Long M; Liu A; Chen Q
Aging (Albany NY); 2023 May; 15(9):3598-3620. PubMed ID: 37155150
[TBL] [Abstract][Full Text] [Related]
80. Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes.
Ding H; Teng Y; Gao P; Zhang Q; Wang M; Yu Y; Fan Y; Zhu L
Hum Mol Genet; 2024 Mar; 33(7):563-582. PubMed ID: 38142284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]